Nirubol Tosakulwong Selected Research

Nirubol Tosakulwong Research Topics

Disease

24	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2013
15	Atrophy 06/2022 - 01/2013
9	Dementia (Dementias) 01/2022 - 06/2013
8	Macular Degeneration (Age-Related Maculopathy) 01/2011 - 04/2008
7	Cognitive Dysfunction 01/2023 - 01/2013
7	Tauopathies 01/2022 - 09/2015
6	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2023 - 01/2020
5	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 11/2020 - 01/2018
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2010
3	Corticobasal Degeneration 11/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 10/2023 - 01/2023
2	Memory Disorders (Memory Loss) 01/2019 - 01/2014
2	Hippocampal Sclerosis 11/2018 - 01/2017
1	Insulin Resistance 11/2023
1	Neoplasms (Cancer) 01/2023
1	Lewy Body Disease (Lewy Body Dementia) 01/2021
1	Pick Disease of the Brain (Pick's Disease) 11/2020
1	Frontotemporal Dementia (Semantic Dementia) 11/2020
1	Parkinsonian Disorders (Parkinsonism) 01/2020
1	Amyloid Plaque 01/2019
1	Multiple Sclerosis 01/2018
1	Apraxias (Dyspraxia) 01/2018
1	Stroke (Strokes) 02/2015
1	Hypertension (High Blood Pressure) 02/2015
1	Atrial Fibrillation 02/2015
1	Disease Susceptibility (Diathesis) 02/2015
1	Diabetes Mellitus 02/2015
1	Ventricular Dysfunction 01/2014
1	Siderosis 10/2013
1	Fuchs' Endothelial Dystrophy 01/2012
1	Hereditary Corneal Dystrophies 09/2010

Drug/Important Bio-Agent (IBA)

14	Amyloid (Amyloid Fibrils)IBA 12/2021 - 01/2013
13	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2023 - 01/2014
8	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2010
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2013
6	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 01/2023 - 01/2018
6	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 01/2020 - 11/2017
6	Amyloid beta-PeptidesIBA 01/2020 - 01/2013
5	ApolipoproteinsIBA 06/2022 - 01/2014
5	Apolipoproteins E (ApoE)IBA 06/2022 - 01/2018
4	Complement Factor H (Factor H)IBA 01/2011 - 01/2009
3	Complement C3 (C3 Complement)IBA 12/2010 - 01/2009
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 01/2017
2	Protons (Proton)IBA 11/2017 - 06/2014
2	Complement Factor B (Factor B)IBA 12/2010 - 01/2009
2	Complement System Proteins (Complement)IBA 01/2010 - 04/2008
1	Insulin (Novolin)FDA Link 11/2023
1	LipidsIBA 11/2023
1	Conjugated (USP) Estrogens (Premarin)FDA Link 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2023
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	Tamoxifen FDA LinkGeneric 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Prostaglandins FIBA 01/2020
1	ProgranulinsIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2019
1	LigandsIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 11/2017
1	Inositol (Myoinositol)IBA 11/2017
1	Apolipoprotein E4IBA 01/2017
1	alpha-SynucleinIBA 01/2017
1	PrionsIBA 04/2016
1	Hormones (Hormone)IBA 01/2016
1	N-terminal proatrial natriuretic peptideIBA 02/2015
1	Atrial Natriuretic Factor (ANF)IBA 02/2015
1	CholesterolIBA 02/2015
1	Natriuretic PeptidesIBA 01/2014
1	HemosiderinIBA 10/2013
1	Transcription Factor 4IBA 01/2012
1	HDL LipoproteinsIBA 04/2010
1	Metalloproteases (Metalloproteinases)IBA 04/2010
1	Complement C2 (Complement Component 2)IBA 01/2009
1	Complement C1 (Complement 1)IBA 01/2009
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2008

Therapy/Procedure

3	Therapeutics 01/2023 - 09/2015
2	Corneal Transplantation (Keratoplasty) 01/2012 - 09/2010
1	Drug Therapy (Chemotherapy) 10/2023
1	Salpingo-oophorectomy 01/2019